S Hirai
- Physiology top 2%
- Alzheimer's disease research and treatments 22
- Neurology top 2%
- Amyotrophic Lateral Sclerosis Research 9
- Neurological diseases and metabolism 8
- Parkinson's Disease Mechanisms and Treatments 6
- Neurology top 2%
- Amyotrophic Lateral Sclerosis Research 9
- Neurological diseases and metabolism 8
- Parkinson's Disease Mechanisms and Treatments 6
-
- Genetic Neurodegenerative Diseases 5
- Psychiatry and Mental health top 5%
-
- Prion Diseases and Protein Misfolding 10
- S100 Proteins and Annexins 5
-
- Neurogenetic and Muscular Disorders Research 5
S Hirai
64 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 104
- Physiology 1.3k
- Neurology 407
- Neurology 688
- Cellular and Molecular Neuroscience 463
- Psychiatry and Mental health 317
Countries citing papers authored by S Hirai
This map shows the geographic impact of S Hirai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Hirai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Hirai more than expected).
Fields of papers citing papers by S Hirai
This network shows the impact of papers produced by S Hirai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Hirai. The network helps show where S Hirai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S Hirai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 18 | |
| 2 | 2001 | 15 | |
| 3 | SECONDARY PREVENTION OF CEREBRAL INFARCTION WITH CILOSTAZOL-A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLED, LONG TERM, RANDOMIZED STUDY (CILOSTAZOL STROKE PREVENTION STUDY, CSPS) | 2000 | 1 |
| 4 | 2000 | 5 | |
| 5 | 1999 | 42 | |
| 6 | 1998 | 74 | |
| 7 | 1997 | 25 | |
| 8 | 1997 | 27 | |
| 9 | 1996 | 60 | |
| 10 | 1995 | 43 | |
| 11 | 1995 | 3 | |
| 12 | 1994 | 19 | |
| 13 | 1991 | 39 | |
| 14 | 1991 | 20 | |
| 15 | 1990 | 54 | |
| 16 | 1990 | 57 | |
| 17 | 1989 | 117 | |
| 18 | 1988 | 243 | |
| 19 | 1988 | 184 | |
| 20 | The fine structure of eosinophilic stages of Alzheimer's neurofibrillary tangles | 1982 | 7 |
About S Hirai
S Hirai is a scholar working on Neurology, Neurology and Physiology, having authored 64 papers that have together received 2.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (22 papers), Prion Diseases and Protein Misfolding (10 papers), Amyotrophic Lateral Sclerosis Research (9 papers), Neurological diseases and metabolism (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Genetic Neurodegenerative Diseases (5 papers), S100 Proteins and Annexins (5 papers) and Neurogenetic and Muscular Disorders Research (5 papers). The work is most often cited by research in Physiology (1.3k citations), Neurology (407 citations) and Neurology (688 citations). S Hirai has collaborated with scholars based in Japan and France. Frequent co-authors include Mikio Shoji, H. Yamaguchi, Mitsunori Morimatsu, Y Harigaya, Yuichi NAKAZATO, Yasuo Ihara, Koichi Okamoto, Masao Watanabe, Tomoaki Shirao and Mitsuhiro Yoshita. Their work appears in journals such as Neurology, Biochemical and Biophysical Research Communications and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.